-+ 0.00%
-+ 0.00%
-+ 0.00%

*Tarsus Pharmaceuticals: Deal Incluses Upfront Consideration of About $450M, Consisting of $270M in Cash and $180M in Tarsus Common Stk >TARS

Dow Jones·08/06/2026 11:18:00

Please log in to view news